Difficulty: Medium
Average Score: 84%
Practice
Key neurotransmitter-based therapeutic strategies for PD include all the following except:
Correct answer
A
Rationale
In Parkinson's disease (PD), the key therapeutic strategy involves targeting dopaminergic pathways due to the loss of dopamine-producing neurons in the substantia nigra. This loss results in an imbalance of neurotransmitters, particularly decreased dopaminergic stimulation. Option C, "Increase dopaminergic stimulation," is correct because it addresses this deficiency by supplementing dopamine or enhancing its effects in the brain.
Option A, "Increase glutamatergic stimulation," is incorrect because increasing glutamate levels can exacerbate excitotoxicity and neuronal damage, which are detrimental in PD. Option B, "Decrease cholinergic stimulation," is incorrect as cholinergic drugs are sometimes used to manage PD symptoms. Option D, "Decrease glutamatergic stimulation," is also incorrect because glutamate is an essential excitatory neurotransmitter in the brain and decreasing its stimulation could lead to negative consequences.
In an educational context, understanding the role of neurotransmitters in PD treatment is crucial for pharmacology students and healthcare providers. This knowledge helps in selecting appropriate therapies and avoiding interventions that may worsen the condition. Students must grasp the rationale behind each option to make informed decisions in clinical practice, ensuring safe and effective management of PD.
Option A, "Increase glutamatergic stimulation," is incorrect because increasing glutamate levels can exacerbate excitotoxicity and neuronal damage, which are detrimental in PD. Option B, "Decrease cholinergic stimulation," is incorrect as cholinergic drugs are sometimes used to manage PD symptoms. Option D, "Decrease glutamatergic stimulation," is also incorrect because glutamate is an essential excitatory neurotransmitter in the brain and decreasing its stimulation could lead to negative consequences.
In an educational context, understanding the role of neurotransmitters in PD treatment is crucial for pharmacology students and healthcare providers. This knowledge helps in selecting appropriate therapies and avoiding interventions that may worsen the condition. Students must grasp the rationale behind each option to make informed decisions in clinical practice, ensuring safe and effective management of PD.